(MCS) Marcus - Ratings and Ratios
Theatres, Hotels, Resorts, Management, Laundry
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 38.1% |
| Value at Risk 5%th | 55.3% |
| Relative Tail Risk | -11.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.96 |
| Alpha | -41.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.547 |
| Beta | 0.883 |
| Beta Downside | 1.157 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.14% |
| Mean DD | 18.95% |
| Median DD | 17.51% |
Description: MCS Marcus October 23, 2025
The Marcus Corporation (NYSE:MCS) is a diversified hospitality and entertainment operator headquartered in Milwaukee. Through its Marcus Theatres, Movie Tavern, and BistroPlex brands, it runs multiscreen movie theaters and a family entertainment center, while its hotel segment includes full-service properties, managed resorts, and condominium-hotel contracts, complemented by ancillary services such as commercial laundry and vacation-ownership management.
Key metrics from recent filings show FY 2023 revenue of roughly $1.5 billion, with the theater segment contributing about 55 % and hotels 45 %. Occupancy rates for its hotels have been trending upward, reaching an average RevPAR of $96, while theater attendance has recovered to ~80 % of pre-pandemic levels, reflecting improved discretionary spending as inflation pressures ease.
Sector drivers that materially affect MCS include consumer confidence (which influences movie-going and travel demand), competition from streaming platforms, and macro-economic trends such as fuel prices that impact travel behavior. Monitoring these variables is essential for forecasting future earnings.
For a deeper, data-driven valuation of MCS, you might explore the analyst tools on ValueRay.
MCS Stock Overview
| Market Cap in USD | 490m |
| Sub-Industry | Movies & Entertainment |
| IPO / Inception | 1990-03-29 |
| Return 12m vs S&P 500 | -38.3% |
| Analyst Rating | 4.75 of 5 |
MCS Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 2.51% |
| Yield on Cost 5y | 3.26% |
| Yield CAGR 5y | 13.29% |
| Payout Consistency | 88.4% |
| Payout Ratio | 125.0% |
MCS Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -1.50% |
| CAGR/Max DD Calmar Ratio | -0.03 |
| CAGR/Mean DD Pain Ratio | -0.08 |
| Current Volume | 183.1k |
| Average Volume | 237.6k |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (7.72m TTM) > 0 and > 6% of Revenue (6% = 45.2m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -1.61pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -12.41% (prev -10.41%; Δ -2.01pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 88.0m > Net Income 7.72m (YES >=105%, WARN >=100%) |
| Net Debt (341.1m) to EBITDA (86.5m) ratio: 3.94 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (31.2m) change vs 12m ago -2.67% (target <= -2.0% for YES) |
| Gross Margin 52.20% (prev 40.38%; Δ 11.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 73.45% (prev 67.70%; Δ 5.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.43 (EBITDA TTM 86.5m / Interest Expense TTM 11.4m) >= 6 (WARN >= 3) |
Altman Z'' 0.92
| (A) -0.09 = (Total Current Assets 50.7m - Total Current Liabilities 144.2m) / Total Assets 1.00b |
| (B) 0.26 = Retained Earnings (Balance) 265.0m / Total Assets 1.00b |
| (C) 0.02 = EBIT TTM 16.3m / Avg Total Assets 1.03b |
| (D) 0.54 = Book Value of Equity 297.2m / Total Liabilities 550.0m |
| Total Rating: 0.92 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.67
| 1. Piotroski 5.0pt |
| 2. FCF Yield 0.21% |
| 3. FCF Margin 0.23% |
| 4. Debt/Equity 0.77 |
| 5. Debt/Ebitda 3.94 |
| 6. ROIC - WACC (= -3.88)% |
| 7. RoE 1.71% |
| 8. Rev. Trend 30.40% |
| 9. EPS Trend 24.41% |
What is the price of MCS shares?
Over the past week, the price has changed by -7.47%, over one month by +12.25%, over three months by -2.27% and over the past year by -30.94%.
Is MCS a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.3 | 57.6% |
| Analysts Target Price | 23.3 | 57.6% |
| ValueRay Target Price | 14.4 | -2.5% |
MCS Fundamental Data Overview November 17, 2025
P/E Trailing = 64.8333
P/E Forward = 25.9067
P/S = 0.6874
P/B = 1.0519
P/EG = 4.1111
Beta = 0.576
Revenue TTM = 753.3m USD
EBIT TTM = 16.3m USD
EBITDA TTM = 86.5m USD
Long Term Debt = 162.0m USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 351.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 341.1m USD (from netDebt column, last quarter)
Enterprise Value = 830.6m USD (489.6m + Debt 351.5m - CCE 10.5m)
Interest Coverage Ratio = 1.43 (Ebit TTM 16.3m / Interest Expense TTM 11.4m)
FCF Yield = 0.21% (FCF TTM 1.72m / Enterprise Value 830.6m)
FCF Margin = 0.23% (FCF TTM 1.72m / Revenue TTM 753.3m)
Net Margin = 1.02% (Net Income TTM 7.72m / Revenue TTM 753.3m)
Gross Margin = 52.20% ((Revenue TTM 753.3m - Cost of Revenue TTM 360.0m) / Revenue TTM)
Gross Margin QoQ = 91.94% (prev 39.52%)
Tobins Q-Ratio = 0.83 (Enterprise Value 830.6m / Total Assets 1.00b)
Interest Expense / Debt = 0.79% (Interest Expense 2.77m / Debt 351.5m)
Taxrate = 32.91% (7.96m / 24.2m)
NOPAT = 10.9m (EBIT 16.3m * (1 - 32.91%))
Current Ratio = 0.35 (Total Current Assets 50.7m / Total Current Liabilities 144.2m)
Debt / Equity = 0.77 (Debt 351.5m / totalStockholderEquity, last quarter 454.3m)
Debt / EBITDA = 3.94 (Net Debt 341.1m / EBITDA 86.5m)
Debt / FCF = 198.6 (Net Debt 341.1m / FCF TTM 1.72m)
Total Stockholder Equity = 452.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.77% (Net Income 7.72m / Total Assets 1.00b)
RoE = 1.71% (Net Income TTM 7.72m / Total Stockholder Equity 452.4m)
RoCE = 2.65% (EBIT 16.3m / Capital Employed (Equity 452.4m + L.T.Debt 162.0m))
RoIC = 1.74% (NOPAT 10.9m / Invested Capital 627.3m)
WACC = 5.62% (E(489.6m)/V(841.1m) * Re(9.27%) + D(351.5m)/V(841.1m) * Rd(0.79%) * (1-Tc(0.33)))
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.83%
[DCF Debug] Terminal Value 65.11% ; FCFE base≈8.49m ; Y1≈5.58m ; Y5≈2.55m
Fair Price DCF = 1.74 (DCF Value 41.3m / Shares Outstanding 23.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 24.41 | EPS CAGR: 52.62% | SUE: 0.17 | # QB: 0
Revenue Correlation: 30.40 | Revenue CAGR: 9.69% | SUE: 0.48 | # QB: 0
Additional Sources for MCS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle